•  
  •  
 

Central Asian Journal of Medicine

Abstract

The authors highlighted the latest modern information on the selection of complex genes at the occurrence of various phenotypes of CHF. The article emphasizes that the selection of optimal group for the recommended drugs, based on the participation of candidate genes in the pathogenesis of the disease, plays an important role in ensuring the effective prevention and prevention of adverse effects of the disease.

First Page

12

Last Page

21

References

1. Brajnik V.A. Izucheniye assotsiatsii polomorfizma genov beta-adrenoretseptorov s urovnem arterialnogo davleniya i razvitiyem gipertrofii miokarda u bol`ni`kh gipertonicheskoy bolezn`yu / V.А. Brajnik, L.О. Minushkina, D.А. Zateyshikov // Ros. med. jurn. - 2010. - № 5. -S. 11–16. 2. Karpova N.Yu., Shostak N.А., Rashid М.А. et al. Kal`tsinirovanni`y aortal`ni`y stenoz. - 2011, Media Sfera: Moskva. p. 126. 3. Lesnyak О.М., Benevolenskaya L.I. Osteoporoz. - 2009, GEOTARМedia: Moskva. p. 272 4. Mareyev V.Yu., Ageyev F.Т., Arutyunov G.P., Natsional`ni`ye Rekomendatsii VNOK i OSSN po diagnostike i lecheniyu KhSN (vtoroy peresmotr) // Serdechnaya nedostatochnost`. -2007. - T. 39. № 1. - S. 4-41. 5. Mareyev V.Yu., Ageyev F.Т., Arutyunov G.P., Natsional`ni`ye Rekomendatsii OSSN, RKO i RNMOT po diagnostike i lecheniyu KhSN (chetverti`y peresmotr) // Jurnal Serdechnaya nedostatochnost`. - 2013. - T. 14. № 7(81). - S. 379-472. 6. Minushkina L.О., Gorshkova Ye.S., Brovkin А.N. i dr. Assotsiatsiya genov beta-adrenoretseptorov, konneksina-40 i kaliyevogo kanala kcnh2 s gipertrofiyey miokarda levogo jeludochka u bol`ni`kh gipertonicheskoy bolezn`yu // Kremlevs. med. klin. vestn. - 2010. - №2. -S. 26–30. 7. Nosikov V.V. Molekulyarnaya genetika arterial`noy gipertenzii u bol`ni`kh sakharni`m diabetom // V kn.: Sakharni`y diabet i arterial`naya gipertenziya, red., Moskva: ООО “Meditsinskoye informatsionnoye agenstvo”, -2006. - S. 70-98. 8. Spitsina Ye.V., Yakunina N.Yu., Chudakova D.А. et.al. Assotsiatsiya polimirfni`kh markerov Pro72Arg i С(-594)СС gena ТР53 s diabeticheskoy polineyropatiyey pri Sakharnom diabete tipa 1 v 431 resskoy populyatsii g.Moskvi` // Molekulyarnaya biologiya. - 2007. - T. 41. № 6. - S. 989-993. 9. Shilov S.N. Khronicheskaya serdechnaya nedostatochnost` pri ishemicheskoy bolezni serdtsa: kliniko-geneticheskiye mekhanizmi` razvitiya i vozmojnosti uluchsheniya ranney diagnostiki, profilaktiki i medikamentoznoy terapii: Avtoref. dis ... d-ra med. nauk. 14.01.05, 14.03.03. – Tomsk, 2011. – 50s. 10. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease //Nat Genet. - 2011. - Vol. 43; №4. - P. 339-44. 11. Adamopoulos S, Kolokathis F, Gkouziouta A, et al. Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy // Cytokine. – 2011. – Vol. 54. – Р. 68–73. 12. Alves, A.J., Eynon, N., Oliveira, J. et al., RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications //World J Cardiol.- 2010. - Vol. 2. №7. -P.187-97. 13. Bleumink G.S., Schut A.F., Sturkenboom M.C. et al. Genetic polymorphisms and heart failure //Genet Med. - 2004. - Vol. 6. №6. - P.465-74. 14. Braunwald E. Heart failure //JACC Heart Fail. - 2013. -Vol.1. №1. - P.1-20. 15. Busiahn A., Li G.H., Faulhaber H.D. et al. Beta-2-adrenegic receptor gene variations, blood pressure and heartsize in normal twins // Hypertension. -2000. - Vol. 35. - P.555–603. 16. Bush W. S., Moore J. H. Chapter 11: Genome-wide association studies. (англ.) // Public Library of Science for Computational Biology. - 2012. - Vol. 8. №12. - P. e1002822. 17. Covolo L., Gelatti U., Metra M. et al. Role of β1 - and β2 - adrenoceptor polymorphisms in heart failure: a case-control study // Eur. Heart J. - 2004. - Vol. 25. - P. 1534-1541. 18. Cresci S., KellyR.J., Cappola T.P. et al.Clinical and genetic modifiers of long-term survival in heart failure //J Am CollCardiol. -2009. - Vol. 54. №5. - P.432-44. 19. Deng A.Y., Genetics of systolic and diastolic heart failure//J.Hypertens.- 2015. - Vol. 33. №1. - P.3-13. 20. Dorn G.W., 2nd, Genetics of common forms of heart failure//CurrOpinCardiol. - 2011. - Vol. 26. №3. - P.204-8. 21. Dupuis J., Langenberg C., Prokopenko I. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk //Nat Genet. - 2010. - Vol. 42. №2. - P.105-16. 22. Ehret G.B., Munroe P.B., Rice K.M. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk //Nature. - 2011. - Vol. 478 (7367). -P.103-9. 23. Forleo C., Resta N., Sorrentino S. et al. Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy // Am. J. Med. - 2004. - Vol. 117. - P. 451-458. 24. Funck-Brentano C., van Veldhuisen D.J., van de Ven L.L et al. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial // Eur J Heart Fail. – 2011. – Vol.13. №7. – Р.765-72. 25. F. Rochais, J.P. Vilardaga, V.O. Nikolaev, M. Developed in collaboration with the Heart Failure Association (HFA) of the ESC//Eur J Heart Fail. - 2012. - Vol.14. №8. P.803-69. 40. Morrison A.C., Felix J.F., Cupples L.A. et al. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium // Circ. Cardio. vasc Genet. - 2010. -Vol.3. №3. - P.248-55. 41. Mozaffarian D., Benjamin E.J., Go A.S. et al. Heart Disease and Stroke Statistics-2015 Update: A Report From the American Heart Association//Circulation. - 2015. – Vol.131.№4. –Р. 434 – 41. 42. O'Donnell, C.J., Nabel, E.G., Genomics of cardiovascular disease//N Engl J Med. -2011. - Vol. 365. №22. -P.2098-109. 43. Papait R., Greco C., Kunderfranco P. et al. Epigenetics: a new mechanism of regulation of heart failure? // Basic Res Cardiol. - 2013. - Vol.108. №4. - P.361-67. 44. Pearson T.A., Manolio T.A. How to interpret a genome-wide association study // JAMA. - 2008. - Vol. 299.№11. - P.1335-1344. 45. Ponikowski P., Voors A., Anker S. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2016: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2016 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC // Eur J Heart Fail. - 2016. - Vol 18. - P. 891–975. 46. Schunkert H., Konig I.R., Kathiresan S. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease//Nat Genet. - 2011. - Vol.43. №4. -P.333- 338. 47. Smith N.L., Felix J.F., Morrison A.C. et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium // CircCardiovasc Genet. - 2010. - Vol.3.№3. - P.256-66. 48. Sotoodehnia N., Siscovick D.S., Vatta M. et al. β2 - Adrenergic receptor genetic variants and risk of sudden cardiac death // Circulation. - 2006. - Vol.113. - P. 1842 - 1848. 49. Teslovich T.M., Musunuru K., Smith A.V. et al., Biological, clinical and population relevance of 95 loci for blood lipids // Nature. - 2010. - Vol.466. №7307. - P.707-13. 50. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. A review of sympathetic nervous system changes in heart failure that also addresses adrenergic receptor polymorphisms and their impact on response to pharmacotherapy // J Am CollCardiol. – 2009. – Vol. 54. – P.1747 - 62. 51. Utkin L.V., Zhuk Y.A., A Genome-Wide Association Study using Pairwise Comparison Matrices (англ.) // SPIIRAS Proceedings. - 2016. - Vol. 4, №47. - P. 225 - 229. 52. Voight B.F., Scott L.J., Steinthorsdottir V. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis //Nat Genet. - - 2010. - Vol.42. №7. -P.579-89. 53. Wallerstedt S.M., Eriksson A.L., Ohlsson C. et al. Haplotype association analysis of the polymorphisms Argl6Gly and Gln27Glu of the adrenergic 2-receptor in a Swedish hypertensive population // J. Hum. Hypertens. - 2005. -Vol. 19. - P.705-708. 54. Wagoner L.E., Craft L.L., Singh B. et al. Polymorphisms of the β2 -adrenergic receptor determine exercise capacity in patients with heart failure // Circ. Res. - 2000. - Vol. 86. -P.834 - 840. 55. Wagoner L.E., Craft L.L., Zengel P. et al. Polymorphisms of the beta1- adrenergic receptor predict exercise capacity in heart failure //Am Heart J. - 2002. - Vol.144.№5. - P.840-46. 56. Wang J., Luben R., Khaw K.T. et al. Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of Cancer (EPIC)-Norfolk Study // Diabetes Care. - 2008. - Vol.31.№11.- P.2120- 25. 57. Velagaleti R.S., O'Donnell C.J., Genomics of heart failure // Heart Fail Clin. - 2010. -Vol.6. №1. - P.115-24.Bunemann, M.J. Lohse, S. Engelhardt Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol // J. Clin. Invest. – 2007. - Vol.117. – P. 229-235. 26. Go A.S., Mozaffarian D., Roger V.L. et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association //Circulation. - 2014. - Vol. 129. №3. -P.28-292. 27. Gullestad L, Ueland T, Vinge LE, et al. Inflammatory cytokines in heart failure: mediators and markers // Cardiology. – 2012. – Vol.122. – P.23-35. 28. Heckbert S.R., Hindorff L.A., Edwards K.L. et al. β2 - Adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly // Circulation. - 2003. -Vol. 107. - P. 2021-2024. 29. Heather M. Davis, Julie A. Johnson. Heart Failure Pharmacogenetics: Past, Present and Future // CurrCardiol Rep. – 2011. – Vol.13. №3. – Р.175 - 184. 30. Iaccarino G., Lanni F., Cipolletta E. et al. The Glu27 allele of the beta2 -adrenergic receptor increases the risk of cardiac hypertrophy in hypertension // J. Hypertens. - 2004. - Vol. 22.№11. - P.2117-2122. 31. Jaillon P., Simon T. Genetic polymorphism of b2 -adrenergic receptor and mortality in ischemic heart disease // Therapie. - 2007. - Vol. 62. - P. 1-7. 32. Kaye D.M., Smirk B., Williams C. et al. β [beta]-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure // Pharmacogenetics. - 2003. -Vol. 3. - P. 379-382. 33. Kathiresan S., Srivastava D. Genetics of human cardiovascular disease //Cell. - 2012. -Vol. 148. №6. - P.1242-57. 34. Kathiresan S., Voight B.F., Purcell S. et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants//Nat Genet. - 2009. - Vol. 41. №3. - P.334-41. 35. Liggett S.B., Cresci S., Kelly R.J. et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure //Nat Med. - 2008. - Vol. 14.№5. -P.510-17. 36. Lopes L.R., Elliott P.M. Genetics of heart failure // BiochimBiophysActa.- 2013. -Vol. 1832. №12. -P.2451-61. 37. M. Petersen, J.T. Andersen, B.R. Hjelvang, K. Broedbaek, S. Afzal, M. Nyegaard, A. D.Borglum, S. Stender, L. Kober, C. Torp-Pedersen, H.E. Poulsen Association of beta- adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heartfailure patients //Br. J. Clin. Pharmacol. – 2011. - №71. – Р.556-565. 38. McNamara D.M., Holubkov R., PostavaL. et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure // Circulation. - 2003. - Vol.107. №12. -P.1598-602. 39. McMurray J.J., Adamopoulos S., Anker S.D. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.

Share

COinS